Registration now open for the SelectScience Virtual Clinical Science Summit 2021
Explore the latest science and technology advancements in regenerative medicine, COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
Explore the latest science and technology advancements in regenerative medicine, COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
Highly complementary cell counting and analysis capabilities bolster preclinical portfolio and enhance QA/QC capabilities in cell and gene therapy and biologics manufacturing
The Simplexa™ SARS-CoV-2 Variants Direct assay aims to enable detection of four mutations associated with virus variants without requiring upfront RNA extraction
Catch up on this on-demand webinar to learn about early and late-onset neonatal hypocalcemia diagnosis
The availability of an International Standard (IS) for antibodies facilitates the standardization of SARS-CoV-2 serological methods
Simplified design reduces manufacturing time and offers improved functionality to help streamline antibody discovery, cell line development, cell therapy, and synthetic biology workflows
Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences
Explore topics from live-cell analysis, in situ hybridization, cancer therapeutics, cell imaging, and much more
Genome editing experts harness the power of CRISPR-Cas enzymes to power the next diagnostic revolution in COVID-19 detection and diagnosis
For a chance to win a $500/£400/450€ Amazon Gift Card, cast your vote for the new products which have made the most difference to clinical diagnostics
In this guest article by RayBiotech Life, learn how to easily obtain IHC positive controls for different pathologies without the need for patient samples
FDA Breakthrough Device Designation for Sepsis, Joint & Implant Infections, Infective Endocarditis, Bacterial Meningitis
In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years
Discover how collaborative research between big pharma and academia is using the latest proteomics platforms to revolutionize drug discovery
Explore topics from HRIM-MS for enhancing structural characterization to microbial monitoring, in situ hybridization and advances in fragrance profiling
Discover how to increase precision and reduce throughput time of your routine electrolyte analyses
Learn how COVID-19 serology testing may inform long-term vaccination strategy and influence short-term prioritization and delivery
Watch this on-demand webinar to learn about the commercial responsibilities of new in vitro diagnostic regulations
Infectious disease expert shares how robust LC columns are facilitating the analysis of complex pathogen samples